Gotowa bibliografia na temat „HBV co-infection”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „HBV co-infection”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "HBV co-infection"

1

Chineze, Helen Ugwu, Nnenna Oketah Edith, Oritsegbubemi Okerentugba Phillip, Frank-Peterside Nnenna, and Omezuruike Okonko Iheanyi. "Serological Evidence of HIV/HBV Co-infection among HIV-infected patients in Onitsha, Anambra State, Nigeria." GSC Biological and Pharmaceutical Sciences 23, no. 3 (2023): 001–8. https://doi.org/10.5281/zenodo.8260283.

Pełny tekst źródła
Streszczenie:
Research suggests that HIV-infected individuals who have also been co-infected with HBV face a greater risk of HIV progression. Hepatitis B and HIV infections pose serious public health challenges in sub-Saharan Africa. This study examined the possible HBV co-infection with the socio-demographic traits of HIV-infected individuals attending the HIV clinic at a referral specialist mission hospital in Onitsha, Anambra State, Nigeria. Two hundred and twenty (220) HIV-infected individuals gave consent to participate in the study. Between March 2022 and October 2022, blood samples (about 5ml) were a
Style APA, Harvard, Vancouver, ISO itp.
2

Singh, S. K. "A Correlative Study of Biochemical, Virological & Histological Parameters of HBV Infection in HIV/HBV Co-Infection." Journal of Medical Science And clinical Research 05, no. 05 (2017): 21258–63. http://dx.doi.org/10.18535/jmscr/v5i5.09.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Sanou-Makan, Konaté, Kayantao Kassoum, Simbo Diakité Seydou, et al. "Frequency of hepatitis and HIV co-infection markers in blood donors at the Hospital Professor Bocar Sidy Sall of Kati-Mali." GSC Biological and Pharmaceutical Sciences 23, no. 2 (2023): 189–96. https://doi.org/10.5281/zenodo.8041517.

Pełny tekst źródła
Streszczenie:
The transmission of infectious agents such as human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV) represents the greatest threat to the safety of blood transfusion to the recipient. The association of HIV infection with HBV and/or HCV is common worldwide, due to shared modes of transmission. The prevalence of HIV-HBV co-infection is estimated to be 5-10% in the United States and 20-30% in Asia and parts of sub-Saharan Africa. Other studies report HCV co-infection in 9-25% of HIV-infected patients. The aim of this study was to determine the frequency of markers of co-in
Style APA, Harvard, Vancouver, ISO itp.
4

Dr Kar H, Dr Kar H., Dr Bhesania Hodiwala A, and Batazoo A. Batazoo A. "A Study of Co-Infection of HBV in HIV Patients." Indian Journal of Applied Research 4, no. 8 (2011): 507–9. http://dx.doi.org/10.15373/2249555x/august2014/132.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ramezani, A., M. Mohraz, A. Aghakhani, et al. "Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals." International Journal of STD & AIDS 20, no. 5 (2009): 336–38. http://dx.doi.org/10.1258/ijsa.2008.008377.

Pełny tekst źródła
Streszczenie:
Association between isolated hepatitis B core antibody (anti-HBc) and hepatitis C virus (HCV) infection has been noted in HIV-infected individuals. This study describes the frequency of isolated anti-HBc and its possible value for the detection of HBV-DNA in HIV-infected patients with or without HCV co-infection. Ninety-two HIV-infected patients were enrolled in the study. Hepatitis B surface antigen (HBs Ag), anti-HBs, anti-HBc, anti-HCV, HIV viral load and CD4 count were tested in all subjects. Then we compared 63 subjects with HIV-HCV co-infection with 29 subjects with HIV infection alone r
Style APA, Harvard, Vancouver, ISO itp.
6

Tumpa, Shanjida Islam, and Abdullah Al Mamun. "HIV/HBV Co-infection - A Global Challenge." Bangladesh Journal of Medical Science 14, no. 4 (2015): 316–22. http://dx.doi.org/10.3329/bjms.v14i4.19392.

Pełny tekst źródła
Streszczenie:
With prevalence worldwide approximately 10% of the HIV-infected population is infected with hepatitis B. In persons with HBV and HIV co-infection, HBV-related liver disease progresses more rapidly than in those with HBV mono-infection leading to increased rates of persistent infection, higher HBV DNA levels, increased cirrhosis and liver-related mortality, increased risk of hepatocellular carcinoma, and decreased efficacy of anti-HBV therapy. Furthermore, HIV-infected patients co-infected with HBV have an increased risk for antiretroviral therapy-related hepatotoxicity. The management of hepat
Style APA, Harvard, Vancouver, ISO itp.
7

Garmaeva, Tatyana Ts, Sergey M. Kulikov, Elena A. Michailova, Andrei B. Sudarikov, Felix P. Filatov, and Valeryi G. Savchenko. "Hepatitis B and Hepatitis C Co-Infection in Patients with Hematological Malignancies." Blood 118, no. 21 (2011): 2090. http://dx.doi.org/10.1182/blood.v118.21.2090.2090.

Pełny tekst źródła
Streszczenie:
Abstract Abstract 2090 BACKGROUND. Coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in immunocompromised patients (pts) with hematological malignancies is not well-studied problem. Early recognition of HBV and HCV infectioning incidence in such pts is difficult due to influence of cytostatic and immunosuppressive therapy and possible mutual HBV or HCV inhibitions. Independence of HBV and HCV infection events has to be discussed. AIM. To determine the prevalence of HBV and HCV co-infection in pts with hematological malignancies to check the possible correlation between the i
Style APA, Harvard, Vancouver, ISO itp.
8

Bhattacharya, D., D. Katzenstein, A. Wong, et al. "Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance." International Journal of STD & AIDS 19, no. 11 (2008): 780–81. http://dx.doi.org/10.1258/ijsa.2008.008020.

Pełny tekst źródła
Streszczenie:
In hepatitis B virus (HBV) monoinfection, alanine aminotransferase (ALT) levels are linearly correlated with HBV DNA levels and lamivudine resistance. In human immunodeficiency virus (HIV)/HBV co-infection, little is known about the association between ALT, HBV DNA, and lamivudine resistance. We assessed HBV DNA, lamivudine resistance and ALT levels in 45 time points in 11 patients with HIV/HBV co-infection during lamivudine-containing antiretroviral therapy. High HBV DNA levels (>106 copies/mL) and lamivudine resistance developed in 45% and 91% of patients, respectively. However, ALT level
Style APA, Harvard, Vancouver, ISO itp.
9

Ranin, J., D. Salemovic, B. Brmbolic, et al. "Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study." Current HIV Research 16, no. 3 (2018): 222–30. http://dx.doi.org/10.2174/1570162x16666180717115614.

Pełny tekst źródła
Streszczenie:
Objective:The study aimed to correlate the status of hepatitis C (HCV) and hepatitis B virus (HBV) co-infection in patients with human immunodeficiency virus (HIV) infection with clinical and demographic data prior to starting highly active antiretroviral therapy (HAART) and assess the impact of HCV and HBV co-infection on the natural history of HIV infection.Patients and Methods:The study involved a total of 836 treatment-naive patients with available serological status for HBV and HCV at the point of therapy initiation. Patients were stratified into four groups: HIV mono-infection, HIV/HCV,
Style APA, Harvard, Vancouver, ISO itp.
10

Mendelson, Marc. "Management of HIV-hepatitis B co-infection." Southern African Journal of HIV Medicine 12, no. 1 (2011): 27–33. http://dx.doi.org/10.4102/sajhivmed.v12i1.209.

Pełny tekst źródła
Streszczenie:
HIV-hepatitis B virus (HBV) co-infected patients are at risk of increased morbidity and mortality. Early recognition of dual infection is a critical factor in directing appropriate therapy, and HBV screening should therefore be undertaken at the time of HIV diagnosis. Vaccination against HBV should be considered for all HIV patients who are not yet infected with HBV. Antiretroviral therapy containing two antiretrovirals active against HBV should be started if the patient either has symptomatic liver disease or is asymptomatic with a CD4 count of
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "HBV co-infection"

1

Rana, Urvi. "Characteristics and Clinical Outcomes in Antiretroviral Treated HIV-HBV Co-infection." Thesis, Université d'Ottawa / University of Ottawa, 2018. http://hdl.handle.net/10393/38118.

Pełny tekst źródła
Streszczenie:
Objective: The objective of this thesis was to compare demographic and clinical characteristics and factors associated with advanced hepatic fibrosis between HIV and HIV-hepatitis B (HBV) co-infected patients. Methods: Proportional odds models were developed to investigate socio-demographic and clinical variables’ association on liver fibrosis determined by AST-to-Platelet-Ratio-Index (APRI). Results: HBV status and APRI values were available for 2,419 of 9,289 (26%) participants. 199 (9%) were HBV co-infected. Compared to HIV infected, HIV-HBV co-infected individuals were 2.19 (95% CI: 1.63
Style APA, Harvard, Vancouver, ISO itp.
2

Wang, Xiao Qian. "The Impact of Hepatitis B co-infection on the HIV Reservoir." Thesis, University of Sydney, 2020. https://hdl.handle.net/2123/22895.

Pełny tekst źródła
Streszczenie:
Hepatitis B virus (HBV) co-infection increases overall and liver-related mortality in people living with HIV, yet the relationship between these two viruses is still poorly understood. We determined whether levels of HIV were associated with markers of HBV infection, immune activation and inflammation or liver damage. We also designed an assay to sequence full-length HIV RNA in order to further validate our findings. HIV-HBV co-infected and HIV mono-infected participants, naïve to ART, were recruited in Bangkok, Thailand as part of a prospective observational cohort study. HIV proviruses were
Style APA, Harvard, Vancouver, ISO itp.
3

Powell, Eleanor A. "Viral Factors Associated with Occult HBV in HIV-positive South Africans." University of Cincinnati / OhioLINK, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1439561912.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Martin, Quigley Christina M. "Characterization of Occult Hepatitis B Virus Infection in HIV-Positive Individuals." University of Cincinnati / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1307441402.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Schmelas, Carolin [Verfasser], and Ralf [Akademischer Betreuer] Bartenschlager. "One for all, all for one: Combining and improving AAV, RNAi and CRISPR technologies to combat HBV infection and HBV/HDV co-infections / Carolin Schmelas ; Betreuer: Ralf Bartenschlager." Heidelberg : Universitätsbibliothek Heidelberg, 2020. http://d-nb.info/1212512278/34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Oliveira, Marina Pedroso de. "Estudo molecular da infecção pelo vírus da hepatite B em pacientes coinfectados pelo HIV, virgens de tratamento, em Goiânia-Goiás." Universidade Federal de Goiás, 2013. http://repositorio.bc.ufg.br/tede/handle/tede/3470.

Pełny tekst źródła
Streszczenie:
Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2014-10-29T14:55:41Z No. of bitstreams: 2 Dissertação - Marina Pedroso de Oliveira - 2013.pdf: 1546029 bytes, checksum: 047574069d3a0ee543cf485aa4e61edd (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)<br>Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2014-10-30T10:52:04Z (GMT) No. of bitstreams: 2 Dissertação - Marina Pedroso de Oliveira - 2013.pdf: 1546029 bytes, checksum: 047574069d3a0ee543cf485aa4e61edd (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306
Style APA, Harvard, Vancouver, ISO itp.
7

Martel, Nora. "Variabilité génétique du virus de l'hépatite B et implication sur le diagnostic et la pathogénèse." Phd thesis, Université Claude Bernard - Lyon I, 2012. http://tel.archives-ouvertes.fr/tel-00865253.

Pełny tekst źródła
Streszczenie:
L'infection chronique ou occulte par le virus de l'hépatite B (HBV) est l'un des facteurs de risque les plusimportants pour le développement de carcinome hépatocellulaire viro-induit. Malgré la petite taille dugénome et les contraintes imposées par l'organisation de ce génome, le HBV présente une grandevariabilité génétique qui est le résultat des erreurs générées lors de l'étape de reverse transcription maisaussi, lors des processus de sélection et d'adaptation. Durant l'infection, une relation étroite hôte-viruss'établit. La population virale est caractérisée par la présence de quasi-espèces
Style APA, Harvard, Vancouver, ISO itp.
8

England, Kirsty Anne. "Paediatric HCV and HIV infection : mode of acquisition, progression and co-infection." Thesis, University College London (University of London), 2008. http://discovery.ucl.ac.uk/1444156/.

Pełny tekst źródła
Streszczenie:
In this thesis a diverse range of topics related to paediatric HIV and HCV infection are investigated information is provided on the more specific areas of coinfection, disease monitoring methodologies and the impact of mode of acquisition of infection. Four unique epidemiological cohorts of vertically and parenterally HIV, HCV and HIV/IICV coinfcctcd children are analysed. ALT reference ranges adjusted for age and sex in children under five years of age show that ALT levels greater than 60U/1 in boys and 55U/1 in girls should be regarded as elevated in the first 18 months of life while therea
Style APA, Harvard, Vancouver, ISO itp.
9

Falconer, Karolin. "HIV-1/HCV co-infection immunity and viral dynamics /." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-762-7/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Fialho, Renata. "Neuropsychiatric manifestations of hepatitis C treatment in HIV/HCV co-infection." Thesis, University of Sussex, 2017. http://sro.sussex.ac.uk/id/eprint/71260/.

Pełny tekst źródła
Streszczenie:
Hepatitis C (HCV) infection is associated with high rates of mortality and morbidity. Interferon alpha based treatment for HCV offers a good rate of viral clearance, however the associated neuropsychiatric side effects increase the risk of treatment interruption and disease progression. The HIV/HCV coinfection is of particular interest due to association with higher rates of HCV treatment side effects and earlier treatment discontinuation when compared with HCV mono-infection. Therefore, the aim of the thesis was to further explore the effect of coinfection on mood and cognition and how HCV in
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "HBV co-infection"

1

Thiemann, Lillian. Double jeopardy: The HIV/HCV co-infection handbook. Community Prescription Service, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

SAARC Tuberculosis and HIV/AIDS Centre, ed. SAARC regional strategy on TB/HIV co-infection: 2011-2015. SAARC Tuberculosis and HIV/AIDS Centre, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Organization), Stop TB Partnership (World Health. A revised framework to address TB-HIV co-infection in the Western Pacific Region. World Health Organization, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Stop TB Partnership (World Health Organization). A revised framework to address TB-HIV co-infection in the Western Pacific Region. World Health Organization, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Southern Africa TB/HIV Co-infection Conference (1994 Gaborone, Botswana). Southern Africa TB/HIV Co-infection Conference: Regional collaboration in T.B. control : Gaborone Sun, 7-11 November, 1994, Gaborone, Botswana. The Republic, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Keleekai, Nowai L. Patterns and Predictors of HIV, Sexually Transmitted Infections, and Staphylococcus Aureus Co-Infection among New York State Prison Inmates. [publisher not identified], 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Barnett, Ben J., and Margaret Hoffman-Terry. HIV/Hepatitis Co-infection. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0039.

Pełny tekst źródła
Streszczenie:
Hepatitis B virus (HBV) infection is common in people living with HIV, and all patients with HIV should be screened for HBV infection. The most common route of transmission worldwide is through perinatal or early childhood exposure, but adult transmission of HBV is often by routes similar to those for HIV, including sexual contact and injection drug use. Although it varies by exposure route, approximately 10% of HIV-positive patients also have chronic HBV infection, and up to 90% have serologic evidence of past exposure to HBV. Long-term complications of HBV infection can include cirrhosis, en
Style APA, Harvard, Vancouver, ISO itp.
8

Price, Jennifer Cohen, Priyanka Amin, and Antoine Douaihy. Hepatitis C and HIV Co-Infection. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0043.

Pełny tekst źródła
Streszczenie:
Chronic infection with hepatitis C virus (HCV) is a leading cause of end-stage liver disease and is the most common indication for liver transplantation in the United States. Because of shared risk factors, individuals living with HIV infection are disproportionately affected by HCV. Moreover, co-infection with HIV accelerates the natural history of chronic HCV infection, increasing the risk of cirrhosis, hepatocellular carcinoma, hepatic decompensation, and death. Highly effective medications such as direct-acting antivirals (DAA) to cure HCV are now available and have the potential to profou
Style APA, Harvard, Vancouver, ISO itp.
9

Decision-Making in HIV/HCV Co-Infection. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2016.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

WHO Regional Office for the Western Pacific. Tuberculosis and HIV: A Framework to Address TB/HIV Co-Infection in the Western Pacific Region. World Health Organization, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "HBV co-infection"

1

Angtuaco, Terence L., and Donald M. Jensen. "HBV and HCV Co-Infection." In Chronic Viral Hepatitis. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-104-6_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Heath, Ryan D., Ali Syed, Suha Abu Khalaf, and Veysel Tahan. "HIV-HBV Co-infection, Clinical Concerns." In Human Viruses: Diseases, Treatments and Vaccines. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-71165-8_20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Galli, Massimo, and Salvatore Sollima. "HBV/HCV Co-infection and Mixed Cryoglobulinemia." In HCV Infection and Cryoglobulinemia. Springer Milan, 2011. http://dx.doi.org/10.1007/978-88-470-1705-4_28.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

den Boer, Margriet, Luis Rivas, and Jorge Alvar. "Co-infection with HIV." In Drug Resistance in Leishmania Parasites. Springer Vienna, 2012. http://dx.doi.org/10.1007/978-3-7091-1125-3_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

den Boer, Margriet, and Jorge Alvar. "Co-infection with HIV." In Drug Resistance in Leishmania Parasites. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-74186-4_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Cunnington, Aubrey, and Eleanor M. Riley. "HIV and Malaria Co-infection." In Immunity to Parasitic Infection. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118393321.ch19.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Moreno, Javier. "HIV and Leishmania Co-infection." In Immunity to Parasitic Infection. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118393321.ch20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Matthews, Gail V., and Gregory J. Dore. "HIV and Hepatitis C Co-Infection." In Advanced Therapy for Hepatitis C. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444346343.ch22.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Talhari, Sinésio, and Carolina Talhari. "Leprosy and HIV/AIDS Co-infection." In Leprosy and Buruli Ulcer. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-89704-8_35.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Talhari, Sinésio, and Carolina Talhari. "Leprosy and HIV/AIDS Co-infection." In Leprosy. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2376-5_34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "HBV co-infection"

1

Angius, Federica. "Effectiveness of B/F/TAF treatment in HIV/HBV co-infection." In Digestive Disease Week 2023, edited by Rachel Giles. Medicom Medical Publishers, 2023. http://dx.doi.org/10.55788/89a1082c.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

"Prevalence of Hepatitis B virus and Haemoparasites among Apparently Healthy Individuals in College of Health Sciences Ladoke Akinola University of Technology Ogbomoso." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/fynm6569.

Pełny tekst źródła
Streszczenie:
Hepatitis B virus (HBV) infection, a viral disease, is of great concern to health community due to its adverse effects on the liver of infected individuals. Haemoparasites are blood-dwelling parasites whose effects span from mild to severe infections. This study focused on Plasmodium falciparum Trypanosoma brucei gambiense and microfilaria which causes malaria, sleeping sickness and microfilaramia in humans respectively. This is a retrospective study that was designed to determine the prevalence of hepatitis B infection and haemoparasistes among apparently healthy individuals in the College of
Style APA, Harvard, Vancouver, ISO itp.
3

Wedemeyer, H., K. Schöneweis, P. Bogomolov, et al. "Safety and Efficacy of 10 mg Myrcludex B/IFNa Combination Therapy in Patients with Chronic HBV/HDV Co-Infection." In 36. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0039-3402105.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Pinto, Carla M. A., and Ana Carvalho. "A Simple Mathematical Model for HIV and HCV Co-Infection." In Modelling, Identification and Control. ACTAPRESS, 2014. http://dx.doi.org/10.2316/p.2014.809-003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Polesca, Helielton Júnior Martins, Josué Silva Aguiar, Luiz Felipe da Cruz Couto, and César Augusto da Silva. "Visceral Leishmaniasis and HIV co-infection: Epidemiological data in the Pernambuco - Bahia health network, 2007-2022." In IV Seven International Congress of Health. Seven Congress, 2024. http://dx.doi.org/10.56238/homeivsevenhealth-029.

Pełny tekst źródła
Streszczenie:
Visceral Leishmaniasis (VL) is a chronic systemic infection caused by the protozoan Leishmania, transmitted by the bite of the Lutzomyia longipalpis mosquito. VL-HIV co-infection, which results from the combination with the human immunodeficiency virus, is considered an emerging disease. This study presents epidemiological data on VL-HIV co-infection in the PEBA Network, from 2007 to 2022, based on records from the Notifiable Diseases Information System (SINAN). Sixty-two confirmed cases of co-infection were analyzed, most of them in men, concentrated mainly in Pernambuco and Bahia. The Juazei
Style APA, Harvard, Vancouver, ISO itp.
6

Pinaffi, Juliana, Leticia Kawano-Dourado, Marcos Tavares, Telma Antunes, and Carmen Barbas. "Co-existence of eosinophilic granulomatosis with polyangiitis, HIV and HCV infection: A rare coincidence?" In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa651.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Puoti, M., A. Tavelli, G. Brancaccio, et al. "P78 Trends in the prevalence and epidemiological characteristics of HDV infection in HBsAg+ persons with or without HIV in Italy: is HIV still a key factor for HDV co-infection?" In Abstracts from the 17° Italian Conference on AIDS and Antiviral Research. BMJ Publishing Group Ltd, 2025. https://doi.org/10.1136/sextrans-icar-2025.145.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Fracella, M., S. Passerini, G. Bugani, et al. "SC-38 High rates of anal polyomaviruses and HPV co-infection among people living with HIV." In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/sextrans-icar-2024.99.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Gheorge, Codrin, Schröder Verginica, Stoicescu Ramona, Honce Adina, and Dumitru Irina. "HPV GENOTYPES COINFECTIONS AND HEALTH RISK - PRELIMINARY STUDY OF THE EAST ROMANIAN POPULATION." In GEOLINKS Conference Proceedings. Saima Consult Ltd, 2021. http://dx.doi.org/10.32008/geolinks2021/b1/v3/10.

Pełny tekst źródła
Streszczenie:
The study aims to identify the degree of infection and co-infection with HPV strains in people of different ages, to assess the risk associated with lack of immunization of the Romanian population. In this study we are looking at the prevalence and relationship of the different types of HPV strains present in the 37 cases with suspected HPV infection that were analyzed, in the period 2018-2019, within the Prodiagnostic analysis laboratory, in Constanța, Romania. Of the total number of people analyzed for the case study, 45.94% (17 out of 37) tested positive for HPV infection. The analysis of t
Style APA, Harvard, Vancouver, ISO itp.
10

Fernandes, Ade, Dyatiara Devy, Damayanti, and Evy Ervianti. "Secondary Syphilis and HIV Co-infection: A Case Series." In The 23rd Regional Conference of Dermatology 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008157303550358.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "HBV co-infection"

1

Haider, Huma. Malaria, HIV and TB in Nigeria: Epidemiology and Disease Control Challenges. Institute of Development Studies (IDS), 2021. http://dx.doi.org/10.19088/k4d.2022.040.

Pełny tekst źródła
Streszczenie:
Nigeria has the world’s highest number of people affected by malaria and the world’s second largest human immunodeficiency virus (HIV)/AIDS burden. There is a high occurrence of co-infection of malaria in HIV patients (Gumel et al., 2021). Nigeria is also ranked as one of the thirty high tuberculosis (TB) and TB-HIV co-infection burden countries in the world (Odume et al., 2020, 8). Co-infection can make each disease more severe and potentially more infectious (Gumel et al., 2021; Jemikalajah et al., 2021; Chukwuocha et al., 2019). This rapid literature review highlights key aspects of the epi
Style APA, Harvard, Vancouver, ISO itp.
2

Saraswati, Lopamudra, Mary Sebastian, Avina Sarna, et al. Prevalence of HIV, hepatitis B and C, and co-infection in a cohort of male injection drug users in Delhi. Population Council, 2013. http://dx.doi.org/10.31899/hiv10.1001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Pełny tekst źródła
Streszczenie:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et a
Style APA, Harvard, Vancouver, ISO itp.
4

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Pełny tekst źródła
Streszczenie:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et a
Style APA, Harvard, Vancouver, ISO itp.
5

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Pełny tekst źródła
Streszczenie:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et a
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!